Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (401-410 of 560) with videos related to

Pageof 56
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Breast Cancer Research and Treatment|June 18, 2017
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)Lori J Goldstein, Fengmin Zhao, Molin Wang, et al.
The American Journal of Cardiology|January 7, 1998
Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flowC M Gibson, J T Dodge, M Goel, et al.
Haematologica|February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 3, 2012
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trialsLinda T Vahdat, Eva S Thomas, Henri H Roché, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 28, 2019
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLCVincenza Ciaramella, Ferdinando Carlo Sasso, Raimondo Di Liello, et al.
Frontiers in Endocrinology|January 25, 2024
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapyLetizia Canu, Clotilde Sparano, Lara Naletto, et al.
Annals of Hematology|October 22, 2024
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trialFabio Efficace, Francesco Sparano, Massimo Breccia, et al.
JCO Oncology Practice|May 27, 2026
Association Between Socioeconomic Inequalities and Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple MyelomaFrancesco Sparano, Gianluca Gaidano, Pasquale Niscola, et al.
JAMA Oncology|September 25, 2025
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical TrialFatima Cardoso, William Jacot, Sherko Kuemmel, et al.
Pageof 56

Showing results (401-410 of 560) with videos related to

Sort By:
Pageof 56
Clinical Lymphoma, Myeloma & Leukemia|February 11, 2018
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)Juan C Ramos, Joseph A Sparano, Michelle A Rudek, et al.
Breast Cancer Research and Treatment|June 18, 2017
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)Lori J Goldstein, Fengmin Zhao, Molin Wang, et al.
The American Journal of Cardiology|January 7, 1998
Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flowC M Gibson, J T Dodge, M Goel, et al.
Haematologica|February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 3, 2012
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trialsLinda T Vahdat, Eva S Thomas, Henri H Roché, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 28, 2019
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLCVincenza Ciaramella, Ferdinando Carlo Sasso, Raimondo Di Liello, et al.
Frontiers in Endocrinology|January 25, 2024
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapyLetizia Canu, Clotilde Sparano, Lara Naletto, et al.
Annals of Hematology|October 22, 2024
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trialFabio Efficace, Francesco Sparano, Massimo Breccia, et al.
JCO Oncology Practice|May 27, 2026
Association Between Socioeconomic Inequalities and Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple MyelomaFrancesco Sparano, Gianluca Gaidano, Pasquale Niscola, et al.
JAMA Oncology|September 25, 2025
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical TrialFatima Cardoso, William Jacot, Sherko Kuemmel, et al.
Pageof 56